S
Senti Biosciences
Team of bioengineers, scientists, and entrepreneurs on a mission to treat the most complex and challenging diseases
About Senti Biosciences
Senti Biosciences is a clinical-stage biotechnology company that specializes in the development of next-generation cell and gene therapies. The company's approach is centered around its proprietary gene circuit platform technology, which allows for the programming of therapeutic cells to respond to specific disease targets and microenvironments.
Senti Bio's primary focus is on the treatment of cancers, with a pipeline of product candidates designed to address various hematologic malignancies and solid tumors. The company is leveraging its platform to create "smarter" medicines that can be controlled and programmed to execute a wide range of therapeutic functions. Its business model revolves around the research and development of these therapies, with the ultimate goal of bringing them to market and providing new treatment options for patients with incurable diseases.
Source: Dealroom company dataAt a glance
- Founded
- 2016
- Headquarters
- South San Francisco, United States
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Pear Ventures
US National Science Foundation
California Institute for Regenerative Medicine
Series A24 investors entered at this stage
NEA
Lux Capital
Amgen Ventures
Omega Funds
Goodman Capital
Menlo Ventures
Allen & Company
8VC
Nest.Bio Labs
Lifeforce Capital
Sahsen Ventures
Bossa Invest
GRIDS Capital
Leaps by Bayer
Matrix Partners China
Alexandria Venture Investments
SmileGate Investment
Ridgeback Capital
Noveus Capital
Intel Capital
Mirae Asset Capital
Gaingels
LifeSci Venture Partners
KB Investment
Series B and later8 investors entered at this stage
Morgan Stanley
ARK Invest
Parker Institute for Cancer Immunotherapy
Invus
T. Rowe Price- DCDynamics Special Purpose Corp
- NMNantahala Capital Management
Celadon Partners
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Senti Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Senti Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.